Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China

Código QR

Medication use patterns, health care resource utilization, and economic burden for patients with major depressive disorder in Beijing, People’s Republic of China

Ling Zhang,1–4 Yun Chen,5 Li Yue,5 Qingjing Liu,6 William Montgomery,7 Lihua Zhi,5 Wanqi Wang51Mood Disorders Center, Beijing Anding Hospital, Capital Medical University, 2China Clinical Research Center for Mental Disorders, 3China Center of Depression, Beijing Institute for Brain Disorder...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang L, Chen Y, Yue L, Liu Q, Montgomery W, Zhi L, Wang W
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	depression China antidepressants healthcare resource persistence Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/f0ceeeb1c6954c8090e823c90bbd6552
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick D, et al.
Publicado: (2016)

Prevalence and correlates of cognitive impairment and depression among elderly people in the world’s fastest growing city, Chongqing, People’s Republic of China
por: Giri M, et al.
Publicado: (2016)

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
por: Bhattacharjee S, et al.
Publicado: (2020)

El diagnóstico diferencial entre la Depresión Bipolar y la Depresión Monopolar en la práctica clínica
por: LEYTON A,FANNY, et al.
Publicado: (2010)

Psicofarmacoterapia antidepresiva
por: Retamal C,Pedro
Publicado: (2001)

Categorical improvements in disease severity in patients with major depressive disorder treated with vilazodone: post hoc analysis of four randomized, placebo-controlled trials
por: Durgam S, et al.
Publicado: (2016)

Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies
por: L. K. Khokhlov, et al.
Publicado: (2019)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi T, et al.
Publicado: (2017)

Depression and the use of antidepressants in cardiovascular diseases from a cardiologist’s perspective
por: Blat Diana, et al.
Publicado: (2021)

Different molecular targets, one purpose – treatment of depression
por: Burat Magdalena, et al.
Publicado: (2020)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
por: Harada E, et al.
Publicado: (2016)

Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder
por: Jha MK, et al.
Publicado: (2017)

¿Es efectivo que los antidepresivos aumentan el riesgo de suicidio?
por: Silva,Hernán, et al.
Publicado: (2007)

Farmacoterapia de los trastornos depresivos unipolares en la mujer
por: Rees,Reginald
Publicado: (2002)

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies
por: Weiller E, et al.
Publicado: (2017)

Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: post hoc analyses of three placebo-controlled studies
por: Thase ME, et al.
Publicado: (2018)

Novel Insights Into the Neurobiology of the Antidepressant Response From Ketamine Research: A Mini Review
por: Michael Colla, et al.
Publicado: (2021)

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
por: Otsubo T, et al.
Publicado: (2018)

Mind your state: Insights into antidepressant nonadherence
por: De Wet Wolmarans, et al.
Publicado: (2016)

Depresión Mayor y Salud Oral: Rol de los Fármacos Antidepresivos
por: Rojas,Gonzalo, et al.
Publicado: (2000)

Preventive Approaches for Post-Stroke Depression: Where Do We Stand? A Systematic Review
por: Woranush W, et al.
Publicado: (2021)

Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data
por: Solem CT, et al.
Publicado: (2016)

Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
por: Park YM, et al.
Publicado: (2016)

The burden of caring for adults with depression and suicidal ideation in five large European countries: analysis from the 2020 National Health and Wellness Survey
por: D. H. Jaffe, et al.
Publicado: (2021)

Cognitive impairment in depression: recent advances and novel treatments
por: Perini G, et al.
Publicado: (2019)

Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study
por: Baune BT, et al.
Publicado: (2021)

Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study
por: Hsing SC, et al.
Publicado: (2020)

Relationship between suicide rate and economic growth and stock market in the People’s Republic of China: 2004–2013
por: Yin HL, et al.
Publicado: (2016)

Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
por: Zeng D, et al.
Publicado: (2018)

Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
por: Wu J, et al.
Publicado: (2015)

The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms
por: Sugawara N, et al.
Publicado: (2020)

Diagnosis and Treatment of Depression in Patients with Schizophrenia
por: Sergey N. Mosolov
Publicado: (2020)

Immunoregulation and antidepressant effect of ketamine
por: Zhang Nan, et al.
Publicado: (2021)

ACHIEVEMENT OF REMISSION AS A MODERN PURPOSE OF ANTIDEPRESSANT THERAPY
por: O. V. Petrunko
Publicado: (2014)

Prevalence and Determinants of Long-Term Utilization of Antidepressant Drugs: A Retrospective Cohort Study
por: Lunghi C, et al.
Publicado: (2020)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
por: Tomita T, et al.
Publicado: (2016)

Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
por: Nuria Carballo, et al.
Publicado: (2021)

Investigation on Internet addiction disorder in adolescents in Anhui, People’s Republic of China
por: Chen Y, et al.
Publicado: (2016)

Prevalence of Asymptomatic Venous Thromboembolism in Depressive Inpatients
por: Takeshima M, et al.
Publicado: (2020)

Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
por: Soraia Silva, et al.
Publicado: (2021)